Ichthyosis
19
3
3
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.5%
2 terminated out of 19 trials
83.3%
-3.2% vs benchmark
11%
2 trials in Phase 3/4
40%
4 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (19)
Defining the Skin and Blood Biomarkers of Ichthyosis
The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis
FARD (RaDiCo Cohort) (RaDiCo-FARD)
Thera-Clean® Microbubbles System in Patients With Skin Diseases
Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO)
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
A Clinical Evaluation of Marula-Derived Ceramide Cream on Skin Barrier Function Enhancement
Reproductive Options in Inherited Skin Diseases
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses
Efficacy of Injectable Gentamicin in Hereditary Ichthyosis
Therapeutic Education Using an Internet Application in Hereditary Ichthyosis
National Registry for Ichthyosis and Related Disorders
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments
A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis